SynthesisBMC cancer2021

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.

He Ba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.